Recombinant Human BMP-5 (CHO-expressed) Protein Summary
Product Specifications
Ala317-His454
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
615-BMC
Formulation | Lyophilized from a 0.2 μm filtered solution in HCl with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in 4 mM HCl containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
615-BMC/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in HCl. |
Reconstitution | Reconstitute at 100 μg/mL in 4 mM HCl. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: BMP-5
Bone Morphogenetic Protein-5 (BMP-5) is one of at least 15 structurally and functionally related BMPs which are members of the transforming growth factor beta (TGF-beta ) superfamily (1). BMP-5 is synthesized as a 454 amino acid (aa) precursor protein that is cleaved at the dibasic cleavage site (RxxR) to release the 20 kDa C-terminal mature protein (2). Mature BMP-5 contains seven conserved cysteine residues involved in formation of the cysteine knot and the single interchain disulfide bond. Biologically active BMP-5 is a disulfide-linked homodimer of the C-terminal mature protein. Mature human BMP-5 shares 96% aa sequence identity with mouse and rat BMP-5. Cellular responses to BMP-5 are mediated by the formation of hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors (1). BMP-5 is expressed by chondrocytes in proliferating and hypertrophic zones of bone growth plates (3). It contributes to limb development by promoting proliferation and differentiation of chondrocytes as well as apoptosis of undifferentiated mesoderm (3, 4). Genetic defects in BMP-5 which cause C-terminal truncation or loss of the proteolytic cleavage site result in multiple skeletal abnormalities, including the short ear phenotype in mice (5, 6). BMP-5 is also expressed by ovarian granulosa cells where it functions as an autocrine factor to promote GC proliferation and inhibit their production of progesterone (7). In the nervous system, BMP-5 promotes dendrite outgrowth and dopaminergic neuronal differentiation (8, 9). It is up-regulated in oral squamous carcinoma cells and induces the apoptosis of some myeloma cell lines (10, 11).
- Chen, D. et al. (2004) Growth Factors 22:233.
- Celeste, A.J. et al. (1990) Proc. Natl. Acad. Sci. 87:9843.
- Mailhot, G. et al. (2008) J. Cell. Physiol. 214:56.
- Zuzarte-Luis, V. et al. (2004) Dev. Biol. 272:39.
- King, J.A. et al. (1994) Dev. Biol. 166:112.
- Ho, A.M. et al. (2008) BMC Dev. Biol. 8:35.
- Pierre, A. et al. (2005) Biol. Reprod. 73:1102.
- Beck, H.N. et al. (2001) BMC Neurosci. 2:12.
- Brederlau, A. et al. (2002) Mol. Cell. Neurosci. 21:367.
- Jin, Y. et al. (2001) Oral Oncol. 37:225.
- Ro, T.B. et al. (2004) Oncogene 23:3024.
Citations for Recombinant Human BMP-5 (CHO-expressed) Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
8
Citations: Showing 1 - 8
Filter your results:
Filter by:
-
G9a Knockdown Suppresses Cancer Aggressiveness by Facilitating Smad Protein Phosphorylation through Increasing BMP5 Expression in Luminal A Type Breast Cancer
Authors: Y Jin, S Park, SY Park, CY Lee, DY Eum, JW Shim, SH Choi, YJ Choi, SJ Park, K Heo
International Journal of Molecular Sciences, 2022-01-06;23(2):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis
Authors: LW Middleton, Z Shen, S Varma, AS Pollack, X Gong, S Zhu, C Zhu, JW Foley, S Vennam, RT Sweeney, K Tu, J Biscocho, O Eminaga, R Nolley, R Tibshirani, JD Brooks, RB West, JR Pollack
JCI Insight, 2019-05-16;5(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
BMP-induced reprograming of the retina into RPE requires WNT signalling in the developing chick optic cup
Authors: J Steinfeld, I Steinfeld, A Bausch, N Coronato, ML Hampel, H Depner, PG Layer, A Vogel-Höpk
Biol Open, 2017-07-15;0(0):.
Species: Chicken
Sample Types: In Vivo
Applications: In Vivo -
A gradient of Bmp7 specifies the tonotopic axis in the developing inner ear.
Authors: Mann Z, Thiede B, Chang W, Shin J, May-Simera H, Lovett M, Corwin J, Kelley M
Nat Commun, 2014-05-20;5(0):3839.
Species: Chicken
Sample Types: Whole Cells
Applications: Bioassay -
Ligand- and stage-dependent divergent functions of BMP signaling in the differentiation of embryonic skeletogenic progenitors in vitro.
Authors: Lorda-Diez C, Montero J, Choe S, Garcia-Porrero J, Hurle J
J Bone Miner Res, 2014-03-01;29(3):735-48.
Species: Chicken
Sample Types: Whole Cells
Applications: Bioassay -
Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs).
Authors: Wu, Qifang, Sun, Chia Chi, Lin, Herbert, Babitt, Jodie L
PLoS ONE, 2012-09-27;7(9):e46307.
Species: Human
Sample Types: Recombinant Protein
Applications: Surface Plasmon Resonance -
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Authors: Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J
Nature, 2012-07-26;487(7408):505-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth.
Authors: Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, Solban N, Sako D, Pearsall RS, Underwood KW, Seehra J, Kumar R, Grinberg AV
J. Biol. Chem., 2011-07-07;286(34):30034-46.
Species: Human, Mouse
Sample Types: Recombinant Protein
Applications: Surface Plasmon Resonance
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human BMP-5 (CHO-expressed) Protein
There are currently no reviews for this product. Be the first to review Recombinant Human BMP-5 (CHO-expressed) Protein and earn rewards!
Have you used Recombinant Human BMP-5 (CHO-expressed) Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image